Key facts
- Baselake Partners, LP filed SCHEDULE 13G/A for Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR).
- Disclosed ownership: 0%.
- Date of event: 11 May 2026.
Baselake Partners, LP - 11 May 2026 SCHEDULE 13G/A Report for Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR)
- Filing Manager
- Baselake Partners, LP
- Reporting Manager
- Baselake Partners, LP
- Symbol
- KZR
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2026, 17:17:44 UTC
- Date of event
- 11 May 2026
- Previous filing
- 06 Apr 2026
- SEC
- View on sec.gov
Key filing fact
Baselake Partners, LP disclosed 0% ownership in Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR) on 11 May 2026.
Change
- Previous schedule filing date: 06 Apr 2026.
- Current filing was accepted on 12 May 2026, 17:17.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baselake Partners, LP | 0% | 0 | 0 | 0 | /s/ David Paolella | David Paolella, Managing Member of Baselake Management, LLC, its investment manager | |
| Baselake Management, LLC | 0% | 0 | 0 | 0 | /s/ David Paolella | David Paolella, Managing Member | |
| David Paolella | 0% | 391,862 | 0 | 0 | /s/ David Paolella | Individually |
CIK / CUSIP context first